Literature DB >> 4274562

Effect of transfer factor therapy on mixed lymphocyte culture reactivity.

B Dupont, M Ballow, J A Hansen, C Quick, E J Yunis, R A Good.   

Abstract

We have studied the effect of dialyzable transfer factor therapy on three patients with immunodeficiency disease and in one patient who demonstrated no evidence of deficiency of either humoral or cellular immunity. We found evidence for nonspecificity in the effect of transfer factor on mixed lymphocyte culture reactivity. The data suggest that in patients with immunodeficiency disease a maturation of lymphocytes may lead to a generalized increased immune responsiveness. More profoundly, our data show that transfer factor may induce changes in the expression of histocompatibility determinants. We observed changes in the expression of determinants capable of stimulating in the mixed lymphocyte culture reaction as well as an increase in the capacity of lymphocytes to respond.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4274562      PMCID: PMC388116          DOI: 10.1073/pnas.71.3.867

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  BIOLOGICAL AND ULTRASTRUCTURAL STUDIES OF LEUCOCYTE FRACTIONS AS TRANSPLANTATION ANTIGENS IN MAN.

Authors:  F T RAPAPORT; J DAUSSET; J M CONVERSE; H S LAWRENCE
Journal:  Transplantation       Date:  1965-07       Impact factor: 4.939

2.  Transfer of delayed hypersensitivity to coccidioidin in man.

Authors:  F T RAPAPORT; H S LAWRENCE; J W MILLAR; D PAPPAGIANIS; C E SMITH
Journal:  J Immunol       Date:  1960-04       Impact factor: 5.422

3.  Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man.

Authors:  H S LAWRENCE; F T RAPAPORT; J M CONVERSE; W S TILLETT
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

4.  Transfer factor.

Authors:  R A Good
Journal:  Cell Immunol       Date:  1972-04       Impact factor: 4.868

5.  Abnormal mixed lymphocyte reactions in the family of a patient with severe combined immunodeficiency.

Authors:  B Dupont; V Andersen; G S Hansen; A Svejgaard
Journal:  Transplantation       Date:  1972-11       Impact factor: 4.939

6.  A typical MLC reactions in HL-A-typed related and unrelated pairs.

Authors:  W Mempel; H Grosse-Wilde; E Albert; S Thierfelder
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

7.  Role of MLC locus and related genes of the chromosomal HL-A region.

Authors:  A Lebrun; M Sasportes; J Dausset
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

8.  A simple micro cytotoxicity test.

Authors:  D B Amos; H Bashir; W Boyle; M MacQueen; A Tiilikainen
Journal:  Transplantation       Date:  1969-03       Impact factor: 4.939

9.  Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.

Authors:  A S Levin; L E Spitler; D P Stites; H H Fudenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

10.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

  10 in total
  5 in total

1.  Inhibitory activity of medium-dialyzed transfer factor on lymphocyte blastogenesis.

Authors:  C Mueller-Eckhardt; R E Ritts
Journal:  Blut       Date:  1976-05

2.  In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.

Authors:  K Nékám; L Kalmár; P Gergely; G Kelemen; B Fekete; I Láng; J Lévai; G Y Petrányi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

3.  Immunologic specificity of transfer factor.

Authors:  K S Zuckerman; J A Neidhart; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

4.  Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.

Authors:  J A Sandler; T K Smith; V C Manganiello; C H Kirkpatrick
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

5.  Transfer factor.

Authors:  A S Hamblin
Journal:  J R Soc Med       Date:  1979-12       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.